-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
:copyright: This article comes from: Xiao Cui and his friends
:copyright: This article comes from: Xiao Cui and his friends
guide
guide _read
For many years, blood-based biomarkers for AD seemed out of reach, but recent results show that they can become a reality.
How these biomarkers are brought into clinical practice will pave the way for blood biomarkers to support the development of diagnosis and treatment of AD and other dementias
Part.
Introduction of Blood Biomarkers of Sporadic AD Introduction of Blood Biomarkers of Sporadic AD Introduction of Blood Biomarkers of SporadicAD Protein (Aβ 1.
Part.
Blood Biomarkers for Hereditary Alzheimer's Disease Blood Biomarkers for Hereditary Alzheimer's Disease AD in rare cases has a single gene-determined etiology, namely mutations in the PSEN1, PSEN2, or APP genes, or the APP gene proliferation genes
Part.
Road to Clinical Implementation Road to ClinicalImplementation Clinical Assay Development and Validation (Phase II)
Part.
Summary and Outlook Summary and Outlook Due to the availability of ultrasensitive detection methods, blood biomarkers for the diagnosis and prognosis of AD are approaching clinical application
leave a message here